Cardiac Panel Test Card (Whole Blood)
- Known as:
- Cardiac Panel Test Card (Whole Blood)
- Catalog number:
- 4s00240
- Product Quantity:
- EUR
- Category:
- -
- Supplier:
- Good Biotech Corp - GBC
- Gene target:
- Cardiac Panel Test Card (Whole Blood)
Related genes to: Cardiac Panel Test Card (Whole Blood)
- Gene:
- MAVS NIH gene
- Name:
- mitochondrial antiviral signaling protein
- Previous symbol:
- -
- Synonyms:
- VISA, KIAA1271, IPS-1, Cardif
- Chromosome:
- 20p13
- Locus Type:
- gene with protein product
- Date approved:
- 2009-04-01
- Date modifiied:
- 2017-09-22
Related products to: Cardiac Panel Test Card (Whole Blood)
Related articles to: Cardiac Panel Test Card (Whole Blood)
- The mitochondrial antiviral signaling protein (MAVS) is a key component of the innate immune response against RNA viruses. Its involvement in other cellular stresses is largely unknown. Here, we found that hypoxia induces MAVS aggregation, leading to the stabilization of HIF1/2α proteins and the enhancement of hypoxia signaling. Mechanistic studies revealed that MAVS enhances TRAF6 binding to ECSIT, which catalyzes ECSIT polyubiquitination. This promotes mitochondrial ROS generation and likely inhibits PHD2 enzymatic activity, thereby reducing HIF1/2α proteasomal degradation. Disrupting MAVS in both mice and zebrafish decreased the expression of hypoxia response genes and reduced the tolerance of zebrafish to hypoxia. This study reveals an unexpected role of MAVS in hypoxia signaling. - Source: PubMed
Publication date: 2026/09/09
Sun XueyiZhu ChunchunLiu WenWang ZixuanDeng HongyanJia ShukeShi ShuaiXiang YuhanLuo YimanGui Jian-FangLiu XingXiao Wuhan - Swine acute diarrhea syndrome coronavirus (SADS-CoV) is a bat-origin porcine enteric alphacoronavirus first identified in Guangdong, China in 2017, which causes severe watery diarrhea and high mortality in neonatal piglets, leading to in substantial economic losses to the global swine industry. Here, we report that SADS-CoV nsp10 functions as an IFN-λ1 antagonist. Specifically, nsp10 suppressed IFN-λ1 production independently of its zinc finger domains. Furthermore, nsp10 inhibits MAVS- and IRF1-driven IFN-λ1 expression within the RLR signaling pathway. Nsp10 blocks poly (I:C)-induced nuclear translocation of IRF1, although no direct physical interaction is detected between the two proteins. Pull-down assays combined with mass spectrometry identified hnRNPU as a nsp10-interacting protein and their direct interaction was verified by co-immunoprecipitation (Co-IP). hnRNPU alone inhibits IFN-λ1 production and synergizes with nsp10 to enhance this suppression, consequently facilitating SADS-CoV replication. Collectively, our findings uncover a previously unrecognized immune evasion mechanism employed by SADS-CoV and provide a potential therapeutic target for controlling coronavirus infections. - Source: PubMed
Publication date: 2026/09/06
Wei XiaonaZhao YukunLiu JiaxinLi JingminZhong ChunhuiZhao KeyuCao YongchangXue Chunyi - The effect of diet on genetic regulation in humans remains largely unexplored. Here, we investigate gene-diet interactions in a unique group of healthy individuals (N = 200) who alternate between omnivory and dietary restriction of animal products for religious reasons. Using longitudinal proteomic and genotype data, we identify diet-responsive cis-pQTLs and highlight regulatory effects on LBR and MSRA, proteins involved in cholesterol and methionine metabolism respectively. LBR-associated cis-pQTL rs74148404 colocalizes with obesity exclusively under dietary restriction, suggesting diet-dependent modulation of genetic risk. We also show that a diet-dependent cis-pQTL for metabolic regulator FGF21 colocalizes with eosinophil and platelet traits pointing to diet-sensitive immunometabolic signalling. By parallel profiling of a continuously omnivorous control group (N = 211), we uncover seasonally dynamic genetic regulation for proteins linked to apoptosis in immune system pathways (MAVS, CASP3, PDLIM7, IL12RB1), effects likely masked by animal product restriction. These findings reveal dynamic diet- and season-sensitive regulatory mechanisms with implications for precision nutrition and individualized disease prevention strategies, and underscore the need to integrate environmental context into genetic studies of health and disease. - Source: PubMed
Publication date: 2026/08/08
Simistiras AlexandrosBocher OzvanEmmanouil ChristinaSkoulakis AnargyrosGlentis StavrosScarmeas NikolaosZeggini EleftheriaRouskas KonstantinosDimas Antigone S - Autophagy-associated protein 13 (ATG13) plays a pivotal role in regulating the assembly of the autophagy initiation complex. However, the function and mechanism of action of ATG13 during influenza virus infection remain incompletely understood. This study elucidates that ATG13 restricts influenza A virus (IAV) replication while potentiating the activation of the type I interferon (IFN-I) pathway. Mechanistically, coimmunoprecipitation assays revealed that ATG13 interacts with MAVS and recruits the E3 ubiquitin ligase ASB1 to catalyze K63-linked polyubiquitination at the K348 residue, thereby amplifying the downstream antiviral signaling cascade. Furthermore, through dual-luciferase reporter assays and pharmacological inhibition of autophagy, we confirmed that this novel immunomodulatory function of ATG13 is independent of the canonical autophagy pathway. The present study identifies ATG13 as a novel host restriction factor against IAV and reveals a nonautophagic role for ATG13 in antiviral innate immunity. - Source: PubMed
Publication date: 2026/09/07
Lu YiyuanChen JialeXiao HuiminLi JinzeWang HaixuLiang TianhaoWang JiaruiPang XueyiCheng MingyangSun YuCui TongPu FeiyangZhan JiaxingZhao YiboBao HongyuYang WentaoJiang YanlongYang GuilianWang JianzhongCao XinWang ChunfengBai XueZeng Yan - This study aims to investigate the inhibitory effect of baicalein on cervical cancer driven by persistent human papillomavirus(HPV) infection and clarify its regulatory mechanism on the mitochondrial antiviral signaling protein(MAVS)-interferon regulatory factor 3(IRF3)-interferon-β(IFN-β) signaling pathway, so as to provide experimental evidence for the clinical transformation of baicalein. AutoDock Vina software was used for molecular docking to predict the binding modes and binding energies of baicalein with MAVS and HPV16 E6 proteins. HPV18-positive HeLa cells and HPV16-positive CaSki cells were cultured in vitro. They were divided into the control group and baicalein groups with low dose(10 μmol·L~(-1)) and high dose(40 μmol·L~(-1)). Meanwhile, the silent MAVS cell model was constructed and divided into the negative control small interfering RNA group(siNC) group, MAVS small interfering RNA(siMAVS) group, siNC + baicalein with high dose(H) group, and siMAVS + baicalein-H group. Cell proliferation and apoptosis were detected by colony formation assay, CCK-8 assay, and flow cytometry. The protein expressions of the MAVS-IRF3-IFN-β pathway and HPV16 E6 were detected by Western blot. A nude mouse model bearing CaSki cell xenografts of cervical cancer was established and randomly divided into five groups with six mice in each group: model group, baicalein with low dose(L) group(10 mg·kg~(-1)), baicalein-H group(40 mg·kg~(-1)), siMAVS + baicalein-H group, and siMAVS + model group. Modeling and administration were completed after anesthesia with pentobarbital sodium. Tumor volume was detected every three days; tumor tissues were stripped and weighed at the end of the experiment; the expressions of pathway-related proteins and oncoproteins in tumor tissues were detected by immunohistochemistry. The results show that the binding energies of baicalein with MAVS and HPV16 E6 proteins are-6.65 and-8.82 kcal·mol~(-1), respectively, with good binding activity. In in vitro experiments, baicalein inhibits the proliferation of HeLa and CaSki cells and promotes their apoptosis in a dose-dependent manner, significantly up-regulating the protein expressions of MAVS, p-IRF3/IRF3, and IFN-β, as well as down-regulating the protein expression of HPV16 E6. After MAVS silencing, the in vitro anti-tumor effect and regulatory pathway effect of baicalein are significantly reversed. In in vivo experiments, there are statistically significant differences in tumor volume, tumor weight, and the expression of related proteins among all groups. The tumor volume and weight in the baicalein-L and baicalein-H groups are significantly lower than those in the model group, with the tumor inhibition rates of 47.22% and 73.61%, respectively. The expressions of MAVS, p-IRF3, and IFN-β in tumor tissues are increased, while the expressions of HPV16 E6 and Ki67 proliferation antigen(Ki67) are decreased. After MAVS silencing, the in vivo tumor inhibition rate of baicalein decreases to 22.22%, and its regulatory pathway effect is significantly weakened. In conclusion, baicalein can directly bind to MAVS and HPV16 E6 proteins and exert an anti-cervical cancer effect driven by persistent HPV infection via activating the MAVS-IRF3-IFN-β mitochondrial antiviral signaling pathway and inhibiting the function of HPV16 E6 oncoprotein. MAVS is a key target for baicalein to exert its anti-tumor effect. - Source: PubMed
Chen JinKang Heng-YuanJiang Yu-HanChen Chen-Chen